Contact us at 914-666-4665

Dr. Daniel Cameron

Board-certified physician with 38+ years specializing in Lyme disease and tick-borne illnesses. Past President of ILADS (International Lyme and Associated Diseases Society) and first author of ILADS treatment guidelines. Dr. Cameron operates a solo practice focused on patient advocacy and evidence-based Lyme disease treatment. He is the author of 1,100+ articles spanning diagnosis, treatment, co-infections, and recovery from tick-borne illnesses. His work challenges conventional approaches that often leave patients undiagnosed or undertreated, emphasizing clinical judgment over rigid adherence to testing criteria that frequently produce false negatives.

Dr. Daniel Cameron
COVID-Lyme-disease

COVID-19: When Lyme disease and tick-borne illnesses may not be considered

COVID-19: When Lyme disease and tick-borne illnesses may not be considered The woman presented with fever, myalgias, diarrhea, and a dry cough. The authors discuss the risk of premature closure in such cases. “Premature closure refers to forming a conclusion and stopping the diagnostic assessment too early in the diagnostic process, in which case alternative

COVID-19: When Lyme disease and tick-borne illnesses may not be considered Read More »

A 25-year-old man with transverse myelitis and Lyme disease

Transverse myelitis and Lyme disease – a case.

Transverse myelitis and Lyme disease – a case. I will be discussing a 25-year-old man with transverse myelitis and Lyme disease. “He showed gradual improvement in gait, motor and sensory functions of his lower extremities along with a resolution of neurogenic bowel.” wrote the authors. The authors added. “He continues to need intermittent self-catheterization for

Transverse myelitis and Lyme disease – a case. Read More »

congenital-transmission-babesia

Congenital Babesia Transmission in Twins

Congenital Babesia Transmission in Twins When Vertical Transmission Affects Only One Twin Congenital babesia is rare—but this case proves it happens. The patient was born at 36 5/7 weeks by C-section. At five-weeks-old the newborn presented to the emergency department with pallor, increased lethargy and difficulty feeding. The newborn was “more difficult to arouse and

Congenital Babesia Transmission in Twins Read More »

lyme-disease-pregnancy

Lyme Disease and Pregnancy: Case Series Findings

Lyme Disease and Pregnancy: Findings from an 11-Patient Case Series Lyme disease and pregnancy remain areas where clinical evidence is limited but important for maternal and fetal care. A case series of pregnant women with Lyme borreliosis (LB) provides insight into possible outcomes and treatment approaches. The first confirmed case of Lyme borreliosis in pregnancy

Lyme Disease and Pregnancy: Case Series Findings Read More »

A Babesia infection 3 weeks after treatment for Lyme disease.

Babesia Symptoms Weeks Later: Understanding Delayed Babesia After Lyme Disease Treatment

Babesia Symptoms Weeks Later: Understanding Delayed Babesia After Lyme Disease Treatment Delayed Babesia may explain why some Lyme disease patients relapse after initially improving with antibiotics. In this case, a 67-year-old woman developed a Babesia infection three weeks after treatment for Lyme disease—raising important questions about how clinicians evaluate and follow these patients. Hoversten and

Babesia Symptoms Weeks Later: Understanding Delayed Babesia After Lyme Disease Treatment Read More »

Babesia-treatment

Tafenoquine: Treatment for relapsing Babesia

Tafenoquine for Relapsing Babesia: A Treatment Option When Standard Therapy Fails For a complete overview of Babesia symptoms, testing, and treatment, visit our Babesia and Lyme disease guide. Tafenoquine Babesia treatment may offer hope for patients who relapse after standard therapy. Patients with relapsing Babesia often present with recurring symptoms such as night sweats, air

Tafenoquine: Treatment for relapsing Babesia Read More »

facial-nerve-dysfunction-lyme-disease

Facial Nerve Dysfunction After Lyme Disease and Steroid Treatment

Facial Nerve Dysfunction After Lyme Disease Treatment Facial nerve dysfunction after Lyme disease treatment can persist for months and may significantly affect quality of life. In their study, Wormser and colleagues found that 6 of 11 Lyme disease patients (54.5%) experienced ongoing facial nerve dysfunction an average of 13.1 months after treatment began with corticosteroids.

Facial Nerve Dysfunction After Lyme Disease and Steroid Treatment Read More »

Anaplasmosis-babesia

Babesia and Anaplasmosis in a Child with Leukemia

Babesia and Anaplasmosis in a Child with Leukemia Babesia immunocompromised patients face elevated risks — and this case shows why clinicians must consider tick-borne infections even in children undergoing cancer treatment. A 5-year-old with leukemia developed both Babesia and Anaplasmosis after a tick bite. “A 5-year-old male with National Cancer Institute (NCI) standard risk B-cell

Babesia and Anaplasmosis in a Child with Leukemia Read More »

anaplasmosis-neurological-symptoms

Anaplasmosis leading to neurological symptoms of trigeminal neuralgia

Anaplasmosis leading to neurological symptoms of trigeminal neuralgia According to the authors, the woman experienced a “sudden onset of severe, lancinating headache in the distribution of the fifth cranial nerve bilaterally.”¹ She had been treated for Lyme disease two months earlier following a tick bite and a rash on her torso. She had since been

Anaplasmosis leading to neurological symptoms of trigeminal neuralgia Read More »